Eight Organizations Presented with PBMI’s 2018 Excellence Award

PLANO, Texas, March 06, 2018 -- The Pharmacy Benefit Management Institute (PBMI) will present eight organizations with a 2018 Excellence Award during its 23^rd Annual National Drug Benefit Conference today in Palm Springs, California. This award program recognizes exceptional contributions across the pharmacy management landscape in the areas of Care Management Strategies, Cost Containment, and Quality Improvement. This year, in recognition of efforts to curb the opioid epidemic, PBMI created a special Excellence Award honoring organizations demonstrating excellence in Opioid Management Strategies.

“Opioid abuse has become a nationwide issue with staggering statistics affecting millions of people across our country,” says Jane Lutz, Executive Director of PBMI.  “We are pleased this year to add a new award category to recognize organizations implementing creative solutions to combat this significant problem.”

The following highlights the organizations that will be awarded in each category:

Care Management Strategies

• CVS Health is recognized for its ScriptPath™ Prescription Schedule tool.
• Southwest Airlines is recognized for the results achieved by combining the evidence-based approach of a specialty management program with their oncology program to implement a split fill program for 19 oncology drugs.
• Texas Oncology is recognized for the success of its Medically Integrated Pharmacy Care model.

Cost Containment

• HealthPartners is recognized for its mandatory Site of Care Program. 

Quality Improvement

• Abarca is recognized for the improvements it helped achieve in medication therapy management (MTM) and comprehensive medication review (CMR) performance for a Medicare Part D health plan.
• PersonalMed is recognized for its pharmacy certification (cCert) credentialing program.

Opioid Management Strategies

• Express Scripts is recognized for its Advanced Opioid Management Solution which manages new and acute opioid users, short-term or intermittent opioid users, patients on long-term/chronic opioid therapy, as well as those patients who may be overusing or abusing opioids.  
• Prime Therapeutics is recognized for its Controlled Substance Management Program. This program includes several components which work in concert to identify and target individuals at risk of misusing controlled substances.

To learn more about these organizations’ programs/approaches, click here.

About PBMI

The Pharmacy Benefit Management Institute is dedicated to unraveling the complexities of pharmacy benefit management by providing research, continuing education, and Web resources that help organizations work effectively with their pharmacy benefit managers to improve the overall management of drug benefit programs. Learn more at www.pbmi.com.

Contact:

Julie Blackman
PBMI
480-730-0814
[email protected]